PierianDx: PierianDx and Biodesix Partner to Advance Lung Cancer Diagnostics

PierianDx, the global leader in clinical genomics knowledge, announced that it has partnered with Biodesix to provide its interpretation technology platform for use with the Biodesix newly launched GeneStrat NGS genomic test, a blood-based tumor profiling test to detect actionable mutations in patients with non-small cell lung cancer.